Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AC.1ORF1abHKU-ORF1bAACRCGCTTAACAAAGCACTC2142.861890918889R-17655.9Hong Kong
AC.1NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
AC.1NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
C.27ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
C.27ORF1abHKU-ORF1bAACRCGCTTAACAAAGCACTC2142.861890918889R-17655.9Hong Kong
C.27NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
C.27NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
B.1.1.421ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
B.1.1.421ORF1abHKU-ORF1bAACRCGCTTAACAAAGCACTC2142.861890918889R-17655.9Hong Kong
B.1.1.421NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
B.1.1.421NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
B.1.1.364ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
B.1.1.364ORF1abHKU-ORF1bAACRCGCTTAACAAAGCACTC2142.861890918889R-17655.9Hong Kong
B.1.1.364NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
B.1.1.364NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
B.1.431ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
B.1.431ORF1abHKU-ORF1bAACRCGCTTAACAAAGCACTC2142.861890918889R-17655.9Hong Kong
B.1.431NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
B.1.431NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
B.1.168ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
B.1.168ORF1abHKU-ORF1bAACRCGCTTAACAAAGCACTC2142.861890918889R-17655.9Hong Kong
B.1.168NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
B.1.168NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
Q.6 (Alpha)ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
Q.6 (Alpha)ORF1abHKU-ORF1bAACRCGCTTAACAAAGCACTC2142.861890918889R-17655.9Hong Kong
Q.6 (Alpha)NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-893.215Hong Kong
Q.6 (Alpha)NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-4478.8Hong Kong
AZ.2ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
AZ.2ORF1abHKU-ORF1bAACRCGCTTAACAAAGCACTC2142.861890918889R-17655.9Hong Kong
AZ.2NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
AZ.2NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
B.1.1.97ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
B.1.1.97ORF1abHKU-ORF1bAACRCGCTTAACAAAGCACTC2142.861890918889R-17655.9Hong Kong
B.1.1.97NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
B.1.1.97NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
B.1.36.18ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
B.1.36.18ORF1abHKU-ORF1bAACRCGCTTAACAAAGCACTC2142.861890918889R-17655.9Hong Kong
B.1.36.18NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
B.1.36.18NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
B.1.177.32ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
B.1.177.32ORF1abHKU-ORF1bAACRCGCTTAACAAAGCACTC2142.861890918889R-17655.9Hong Kong
B.1.177.32NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
B.1.177.32NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
B.1.1.59ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
B.1.1.59ORF1abHKU-ORF1bAACRCGCTTAACAAAGCACTC2142.861890918889R-17655.9Hong Kong
B.1.1.59NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
B.1.1.59NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
B.1.177.67ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
AA.4NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
AA.4NHKU-NCGAAGGTGTGACTTCCATG1952.632925429236R-20936.4Hong Kong
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used